{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T17:18:31Z","timestamp":1720372711804},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81001342"],"award-info":[{"award-number":["81001342"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012336","name":"major state basic research development program of China","doi-asserted-by":"crossref","award":["2011CB512110"],"award-info":[{"award-number":["2011CB512110"]}],"id":[{"id":"10.13039\/501100012336","id-type":"DOI","asserted-by":"crossref"}]},{"name":"national mega project on major infectious diseases prevention","award":["2012ZX10001005-006"],"award-info":[{"award-number":["2012ZX10001005-006"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.jviromet.2015.03.007","type":"journal-article","created":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T23:15:04Z","timestamp":1427757304000},"page":"1-9","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Immunogenicity and virulence of attenuated vaccinia virus Tian Tan encoding HIV-1 muti-epitope genes, p24 and cholera toxin B subunit in mice"],"prefix":"10.1016","volume":"219","author":[{"given":"Shouwen","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cunxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maopeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronglan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningyi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2015.03.007_bib0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nature10660","article-title":"Antibody-based protection against HIV infection by vectored immunoprophylaxis","volume":"481","author":"Balazs","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature10766","article-title":"Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys","volume":"482","author":"Barouch","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0015","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/317813a0","article-title":"Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype","volume":"317","author":"Buller","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0020","doi-asserted-by":"crossref","first-page":"e13983","DOI":"10.1371\/journal.pone.0013983","article-title":"Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate","volume":"5","author":"Currier","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0025","doi-asserted-by":"crossref","first-page":"17477","DOI":"10.1073\/pnas.0707399104","article-title":"Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens","volume":"104","author":"DeVico","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jviromet.2015.03.007_bib0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jviromet.2012.06.022","article-title":"Construction and evaluation of a new triple-gene expression cassette vaccinia virus shuttle vector","volume":"185","author":"Du","year":"2012","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0035","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0040","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.virol.2005.02.014","article-title":"Host range, growth property, and virulence of the smallpox vaccine: vaccinia virus Tian Tan strain","volume":"335","author":"Fang","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0045","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/428404","article-title":"Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection","volume":"191","author":"Flynn","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2015.03.007_bib0050","doi-asserted-by":"crossref","first-page":"e12395","DOI":"10.1371\/journal.pone.0012395","article-title":"Immunogenic profiling in mice of a HIV\/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions","volume":"5","author":"Garcia-Arriaza","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0060","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1086\/428405","article-title":"Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial","volume":"191","author":"Gilbert","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2015.03.007_bib0055","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1086\/654816","article-title":"Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine","volume":"202","author":"Gilbert","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2015.03.007_bib0065","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.1016\/j.vaccine.2011.06.085","article-title":"Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review","volume":"29","author":"Girard","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0070","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1016\/j.vaccine.2006.09.090","article-title":"Head-to-head comparison on the immunogenicity of two HIV\/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B","volume":"25","author":"Gomez","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0075","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/j.vaccine.2006.11.051","article-title":"Generation and immunogenicity of novel HIV\/AIDS vaccine candidates targeting HIV-1 Env\/Gag-Pol-Nef antigens of clade C","volume":"25","author":"Gomez","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0080","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1016\/j.vaccine.2009.03.049","article-title":"Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens","volume":"27","author":"Gomez","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0085","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature10003","article-title":"Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine","volume":"473","author":"Hansen","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20071331","article-title":"An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses","volume":"205","author":"Harari","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jviromet.2015.03.007_bib0095","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.vaccine.2006.05.129","article-title":"Influenza vaccine effectiveness among 50\u201364-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003\u20132004","volume":"25","author":"Herrera","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/gt.2009.132","article-title":"Lister strain vaccinia virus, a potential therapeutic vector targeting hypoxic tumours","volume":"17","author":"Hiley","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.jviromet.2015.03.007_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2009.06.006","article-title":"Vaccinia virus vaccines: past, present and future","volume":"84","author":"Jacobs","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jviromet.2015.03.007_bib0110","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1016\/j.vaccine.2008.03.044","article-title":"Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: scarification vaccination","volume":"26","author":"Jentarra","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0115","doi-asserted-by":"crossref","first-page":"e31979","DOI":"10.1371\/journal.pone.0031979","article-title":"Attenuation of vaccinia Tian Tan strain by removal of viral TC7L-TK2L and TA35R genes","volume":"7","author":"Kan","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0120","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.vaccine.2010.12.104","article-title":"A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects","volume":"29","author":"Keefer","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0125","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1016\/j.vaccine.2006.03.087","article-title":"LC16m8: an attenuated smallpox vaccine","volume":"24","author":"Kenner","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0130","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1086\/650299","article-title":"A phase 1\/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172)","volume":"201","author":"Kibuuka","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2015.03.007_bib0135","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0042-6822(92)91233-K","article-title":"A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine","volume":"190","author":"Konishi","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0140","doi-asserted-by":"crossref","first-page":"958404","DOI":"10.1155\/2012\/958404","article-title":"Protection against SHIV-KB9 infection by combining rDNA and rFPV vaccines based on HIV multiepitope and p24 protein in Chinese rhesus macaques","volume":"2012","author":"Li","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.jviromet.2015.03.007_bib0145","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s11434-006-1571-9","article-title":"Immune responses of a designed HIV-1 DNA vaccine on rhesus monkeys","volume":"51","author":"Lishu","year":"2006","journal-title":"Chin. Sci. Bull."},{"key":"10.1016\/j.jviromet.2015.03.007_bib0150","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1128\/JVI.02216-07","article-title":"Differential CD4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primates","volume":"82","author":"Mooij","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2015.03.007_bib0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.virol.2007.04.010","article-title":"DNA\/MVA HIV-1\/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge","volume":"366","author":"Nigam","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0160","doi-asserted-by":"crossref","first-page":"e16902","DOI":"10.1371\/journal.pone.0016902","article-title":"Phylodynamics of HIV-1 from a phase III AIDS vaccine trial in Bangkok, Thailand","volume":"6","author":"Perez-Losada","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0165","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.jviromet.2015.03.007_bib0170","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jviromet.2015.03.007_bib0175","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.2009.289","article-title":"Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8","volume":"301","author":"Saito","year":"2009","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jviromet.2015.03.007_bib0180","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/QAD.0b013e32835474d2","article-title":"The design and evaluation of HIV-1 vaccines","volume":"26","author":"Saunders","year":"2012","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0185","first-page":"347","article-title":"Adjuvant effects of dual costimulatory molecules on cellular responses to HIV multipleepitope DNA vaccination","volume":"25","author":"Shen","year":"2009","journal-title":"Chem. Res. Chin. Univ."},{"key":"10.1016\/j.jviromet.2015.03.007_bib0190","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.vaccine.2008.10.051","article-title":"Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial","volume":"27","author":"Spearman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0195","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0042-6822(92)90752-B","article-title":"NYVAC: a highly attenuated strain of vaccinia virus","volume":"188","author":"Tartaglia","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0200","doi-asserted-by":"crossref","first-page":"8899","DOI":"10.1128\/JVI.01053-06","article-title":"Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway","volume":"80","author":"Townsley","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2015.03.007_bib0205","doi-asserted-by":"crossref","first-page":"e8816","DOI":"10.1371\/journal.pone.0008816","article-title":"Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B\u2032\/C candidate vaccine","volume":"5","author":"Vasan","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0210","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.vaccine.2007.11.045","article-title":"Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination","volume":"26","author":"Vijaysri","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0215","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.antiviral.2012.10.002","article-title":"Characterization of an attenuated TE3L-deficient vaccinia virus Tian Tan strain","volume":"96","author":"Wang","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jviromet.2015.03.007_bib0220","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/icb.2010.118","article-title":"Human immunodeficiency virus-1 vaccine design: where do we go now?","volume":"89","author":"Wijesundara","year":"2010","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jviromet.2015.03.007_bib0225","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11427-007-0017-1","article-title":"Construction and characterization of a recombinant fowlpox virus containing HIV-1 multi-epitope-p24 chimeric gene in mice","volume":"50","author":"Zhang","year":"2007","journal-title":"Sci. China Ser. C"},{"key":"10.1016\/j.jviromet.2015.03.007_bib0230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jviromet.2007.03.012","article-title":"The attenuation of vaccinia Tian Tan strain by the removal of the viral M1L-K2L genes","volume":"144","author":"Zhu","year":"2007","journal-title":"J. Virol. Methods"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016609341500083X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016609341500083X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T22:18:27Z","timestamp":1589494707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016609341500083X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":46,"alternative-id":["S016609341500083X"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2015.03.007","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and virulence of attenuated vaccinia virus Tian Tan encoding HIV-1 muti-epitope genes, p24 and cholera toxin B subunit in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2015.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}